Bisphosphonates and atypical femoral fractures.
Silverman
Stuart L
SL
Ott
Susan M
SM
Dell
Richard M
RM
D019386:Alendronate / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006620:Hip Fractures / Q000139:chemically induced*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects; D015994:Incidence; D013997:Time Factors; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D019386:Alendronate